Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
51.18 USD | -1.08% | -3.10% | -18.49% |
Apr. 24 | Oppenheimer Adjusts Incyte Price Target to $84 From $92, Maintains Outperform Rating | MT |
Apr. 23 | Transcript : Escient Pharmaceuticals, Inc., Incyte Corporation - M&A Call |
Financials (USD)
Sales 2024 * | 4.13B | Sales 2025 * | 4.59B | Capitalization | 11.62B |
---|---|---|---|---|---|
Net income 2024 * | 797M | Net income 2025 * | 991M | EV / Sales 2024 * | 1.76 x |
Net cash position 2024 * | 4.37B | Net cash position 2025 * | 5.68B | EV / Sales 2025 * | 1.29 x |
P/E ratio 2024 * |
15.1
x | P/E ratio 2025 * |
12
x | Employees | 2,524 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.41% |
Latest transcript on Incyte Corporation
1 day | -2.33% | ||
1 week | -4.03% | ||
Current month | -11.02% | ||
1 month | -11.81% | ||
3 months | -16.79% | ||
6 months | -6.56% | ||
Current year | -19.27% |
Managers | Title | Age | Since |
---|---|---|---|
Herve Hoppenot
CEO | Chief Executive Officer | 64 | 14-01-12 |
Director of Finance/CFO | 53 | 19-02-10 | |
Pablo Cagnoni
PSD | President | 60 | 23-06-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Julian Baker
BRD | Director/Board Member | 57 | 00-12-31 |
Edmund Harrigan
BRD | Director/Board Member | 71 | 19-12-15 |
Director/Board Member | 70 | 15-01-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.55% | 215 M€ | +12.86% | - | |
2.94% | 1 M€ | 0.00% | - | |
2.88% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 51.18 | -1.08% | 1 771 923 |
24-04-24 | 51.74 | +0.17% | 1,564,434 |
24-04-23 | 51.65 | -0.52% | 2,493,676 |
24-04-22 | 51.92 | -0.82% | 1,751,676 |
24-04-19 | 52.35 | -0.89% | 2,181,297 |
Delayed Quote Nasdaq, April 25, 2024 at 10:06 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.27% | 11.62B | |
-2.86% | 87.31B | |
+3.95% | 40.86B | |
-21.64% | 29.36B | |
+57.92% | 24.49B | |
-14.16% | 17.31B | |
-13.96% | 11.31B | |
-44.23% | 11.26B | |
+5.84% | 8.31B | |
-9.82% | 7.9B |
- Stock Market
- Equities
- INCY Stock